Open-label, Randomized, and Multicentric Phase III Clinical Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV-1-infected Patients With CD4-positive T-lymphocytes Counts Above 200 permm3 ANRS HB 03 VIHVAC-B
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics; Registrational
- Acronyms VIHVAC-B
- 23 Jul 2013 Biomarkers information updated
- 13 Apr 2011 Results published in JAMA: the Journal of the American Medical Association.
- 19 Feb 2010 Positive results have been presented at the 17th Conference on Retroviruses and Opportunistic Infections.